ipscell.com
Advanced Cell Technology (ACT) Revs Up Pre-Clinical Studies for MS - The Niche
more good news from leading stem cell biotech Advanced Cell Technology (ACT) on preclinical rodent studies using stem cells on MS
Professor Paul Knoepfler, Ph.D.
